Therapeutic targeting of interleukin-22 for severe paediatric urinary tract infection and associated renal complications

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/2000483

Funding Status
Status not available

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Urinary tract infections are among the most common bacterial infections and are associated with the development of chronic kidney disease. The bacteria that cause these infections are becoming increasingly resistant to antibiotic therapy. Therefore, new strategies that target the immune system rather than the bacteria are urgently needed. This study will provide evidence for re-purposing novel immunotherapies targeting the protein interleukin-22 that are being developed for other diseases.

Funded Activity Details

Start Date: 01-01-2020

End Date: End date not available

Funding Scheme: Ideas Grants

Funding Amount: $997,139.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

bacterial infection | immunotherapy | interleukins (il) | urinary tract infection (uti)

Related Links